- Tytuł:
- The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
- Autorzy:
- Źródło:
- Journal of translational medicine [J Transl Med] 2022 Aug 16; Vol. 20 (1), pp. 371. Date of Electronic Publication: 2022 Aug 16.
- Typ publikacji:
- Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Cell-Free Nucleic Acids*/genetics
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/genetics
Biomarkers, Tumor/genetics ; Carcinoma, Renal Cell ; DNA ; Humans ; Immunotherapy ; Liquid Biopsy ; Prospective Studies ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Receptors, Vascular Endothelial Growth Factor ; Tumor Suppressor Protein p53/genetics ; Vascular Endothelial Growth Factor A - SCR Disease Name:
- Clear-cell metastatic renal cell carcinoma
Czasopismo naukowe